MSCI ACWI IMI Genomic Innovation Index

The MSCI ACWI IMI Genomic Innovation Index, developed in collaboration with ARK Invest, is based on the MSCI ACWI IMI Index, its parent index, and includes large, mid and small-cap securities across Developed Markets (DM) and Emerging Markets (EM) countries. The Index aims to represent the performance of a set of companies that are associated with the development of new products and services in the field of genomic sequencing, synthesis, analysis or instrumentation, enabling bio computing, bioinformatics, molecular diagnostics and agricultural biotechnology.